Panagene Inc (KQ:046210) — Market Cap & Net Worth
Market Cap & Net Worth: Panagene Inc (046210)
Panagene Inc (KQ:046210) has a market capitalization of $33.71 Million (₩49.75 Billion) as of June 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #23427 globally and #1567 in its home market, demonstrating a 9.40% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Panagene Inc's stock price ₩1548.00 by its total outstanding shares 32136700 (32.14 Million). Review 046210 current and long-term liabilities to assess the company's total debt and financial obligations.
Panagene Inc Market Cap History: 2015 to 2026
Panagene Inc's market capitalization history from 2015 to 2026. Data shows change from $97.79 Million to $33.71 Million (-9.76% CAGR).
Index Memberships
Panagene Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$270.08 Billion | 0.01% | #795 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$270.08 Billion | 0.01% | #795 of 1384 |
Weight: Panagene Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Panagene Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Panagene Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Panagene Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $97.79 Million | $5.92 Billion | -$629.74 Million | 0.02x | N/A |
| 2016 | $148.53 Million | $6.96 Billion | -$1.56 Billion | 0.02x | N/A |
| 2017 | $184.68 Million | $7.39 Billion | -$6.96 Billion | 0.02x | N/A |
| 2018 | $98.98 Million | $7.70 Billion | -$4.12 Billion | 0.01x | N/A |
| 2019 | $51.07 Million | $7.95 Billion | $3.50 Billion | 0.01x | 0.01x |
| 2020 | $93.76 Million | $16.27 Billion | $4.92 Billion | 0.01x | 0.02x |
| 2021 | $82.65 Million | $15.60 Billion | $4.97 Billion | 0.01x | 0.02x |
| 2022 | $92.34 Million | $14.17 Billion | $2.24 Billion | 0.01x | 0.04x |
| 2023 | $89.95 Million | $12.25 Billion | -$4.82 Billion | 0.01x | N/A |
| 2024 | $61.42 Million | $13.20 Billion | -$1.94 Billion | 0.00x | N/A |
Competitor Companies of 046210 by Market Capitalization
Companies near Panagene Inc in the global market cap rankings as of June 19, 2026.
Key companies related to Panagene Inc by market ranking:
- Peptron Inc (KQ:087010): Ranked #5927 globally with a market cap of $2.25 Billion USD ( ₩3.32 Trillion KRW).
- Bioneer Corporation (KQ:064550): Ranked #18761 globally with a market cap of $114.71 Million USD ( ₩169.27 Billion KRW).
- MEDIPOST Co. Ltd (KQ:078160): Ranked #19067 globally with a market cap of $105.79 Million USD ( ₩156.10 Billion KRW).
- Macrogen Inc (KQ:038290): Ranked #19620 globally with a market cap of $91.68 Million USD ( ₩135.29 Billion KRW).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #5927 | Peptron Inc | KQ:087010 | $2.25 Billion | ₩216500.00 |
| #18761 | Bioneer Corporation | KQ:064550 | $114.71 Million | ₩7660.00 |
| #19067 | MEDIPOST Co. Ltd | KQ:078160 | $105.79 Million | ₩10150.00 |
| #19620 | Macrogen Inc | KQ:038290 | $91.68 Million | ₩13500.00 |
Panagene Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Panagene Inc's market cap moved from $97.79 Million to $ 33.71 Million, with a yearly change of -9.76%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩33.71 Million | -10.83% |
| 2025 | ₩37.81 Million | -38.44% |
| 2024 | ₩61.42 Million | -31.72% |
| 2023 | ₩89.95 Million | -2.59% |
| 2022 | ₩92.34 Million | +11.73% |
| 2021 | ₩82.65 Million | -11.85% |
| 2020 | ₩93.76 Million | +83.58% |
| 2019 | ₩51.07 Million | -48.40% |
| 2018 | ₩98.98 Million | -46.40% |
| 2017 | ₩184.68 Million | +24.34% |
| 2016 | ₩148.53 Million | +51.89% |
| 2015 | ₩97.79 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of Panagene Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $33.71 Million USD |
| MoneyControl | $33.71 Million USD |
| MarketWatch | $33.71 Million USD |
| marketcap.company | $33.71 Million USD |
| Reuters | $33.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Panagene Inc
Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company a… Read more